Offering priced. Last Friday, June 24, 2022, BioSig Technologies priced a public offering of common shares on a "best efforts" basis. The offering was for up to 4.666667 million shares at a price of $0.75 per share. The offering closed on June 29, 2022 with 4.341667 million shares sold, and proceeds to the company of around $2.9 million. A bit unexpected, timing-wise, but supports PURE EP commercialization. BioSig had filed an ATM agreement for up to $10 million May 17, 2022 but chose an alternative "best efforts" offering instead. While we expected funding needs in the third quarter, we are bit surprised the Company raised funds now. That said, BioSig is ramping up commercial activities as they shift to a national strategy. Read More >>